NextGen Healthcare, Inc provides healthcare technology solutions in the United States.
infoNextGen Healthcare is a small cap stock with a total market cap of 1.16B.
infoThey trade on the NASDAQ and had their IPO 40 years and 8 months ago.
infoNextGen Healthcare currently employs 2783 people.
infoAs of Wednesday, Aug 23 2023, NextGen Healthcare’s share price is $17.24.
News Relating to NextGen Healthcare
Zacks Investment Research
NextGen (NXGN) Behavioral Health Suite to Address Mental Health
Wednesday Aug 23 2023 at 14:17
NextGen’s (NXGN) Behavioral Health Suite is expected to ease state reporting and enable the secure sharing of patient information across providers.
Reuters
Exclusive: Healthcare software vendor NextGen explores sale, sources say
Wednesday Aug 23 2023 at 13:56
NextGen Healthcare , a provider of software that helps manage patients’ records, is exploring options that include a sale of the company, according to people familiar with the matter.
Zacks Investment Research
Nextgen Healthcare (NXGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Monday Jul 24 2023 at 19:51
While the top- and bottom-line numbers for Nextgen Healthcare (NXGN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research
Nextgen Healthcare (NXGN) Q1 Earnings and Revenues Beat Estimates
Monday Jul 24 2023 at 19:06
Nextgen Healthcare (NXGN) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.16 per share a year ago.
Seeking Alpha
NextGen Healthcare Sees Higher Growth Ahead Amid Operating Improvements
Tuesday Jul 18 2023 at 17:02
NextGen Healthcare, Inc. provides a range of managed software and service solutions to the U.S. healthcare industry. Management has guided fiscal 2024 revenue growth slightly higher than the previous year, and operating profits are growing. I’m cautiously optimistic on the firm’s prospects now that the false claims settlement is quantified, so my outlook for NextGen Healthcare stock is a Buy at around $17.00 per share.
Reuters
NextGen Healthcare to pay $31 mln to settle false claims act allegations -Justice Dept.
Friday Jul 14 2023 at 12:07
Electronic health records vendor NextGen Healthcare Inc has agreed to pay $31 million to resolve allegations that the company violated the False Claims Act, the U.S. Justice Department said on Friday.
Zacks Investment Research
3 Reasons to Retain NextGen (NXGN) Stock in Your Portfolio
Tuesday Jul 04 2023 at 12:15
NextGen’s (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.
Zacks Investment Research
NextGen (NXGN) Expands Partnership With Large Urology Group
Thursday Jun 15 2023 at 08:32
NextGen’s (NXGN) cloud-based healthcare technology solution, Enterprise EHR, is selected by Associated Urologists of North Carolina to create an integrated platform, especially for urology-specific workflows.
Zacks Investment Research
NextGen (NXGN) Q4 Earnings Top Estimates, Revenues Surge Y/Y
Wednesday May 17 2023 at 15:06
NextGen’s (NXGN) fourth-quarter fiscal 2023 results reflect strength in both its revenue sources.
Seeking Alpha
NextGen Healthcare, Inc. (NXGN) Q4 2023 Earnings Call Transcript
Tuesday May 16 2023 at 22:41
NextGen Healthcare, Inc. (NASDAQ:NXGN ) Q4 2023 Earnings Conference Call May 16, 2023 5:00 PM ET Company Participants James Hammerschmidt – SVP, Finance & Investor Relations David Sides – CEO, President & Director James Arnold – EVP & CFO Conference Call Participants Anna Kruszenski – SVB Securities Jack Wallace – Guggenheim Securities Jeffrey Garro – Stephens Inc. Eduardo Ron – Truist Securities Vishal Patel – Piper Sandler & Co. George Hill – Deutsche Bank Operator Welcome to the NextGen Healthcare Fiscal 2023 Fourth Quarter Results Conference Call. Hosting the call today from NextGen are David Sides, President and Chief Executive Officer; and Jamie Arnold, Chief Financial Officer.
Zacks Investment Research
Nextgen Healthcare (NXGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Tuesday May 16 2023 at 19:43
While the top- and bottom-line numbers for Nextgen Healthcare (NXGN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research
Nextgen Healthcare (NXGN) Q4 Earnings and Revenues Surpass Estimates
Tuesday May 16 2023 at 19:00
Nextgen Healthcare (NXGN) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.19 per share a year ago.
Zacks Investment Research
NextGen (NXGN) Behavioral Health Suite to Focus on Mental Health
Thursday May 11 2023 at 14:26
NextGen’s (NXGN) Behavioral Health Suite is expected to offer better access to care and improve patient outcomes.
TechCrunch
NextGen Healthcare says hackers accessed personal data of more than 1 million patients
Monday May 08 2023 at 10:07
NextGen Healthcare, a U.S.-based provider of electronic health record software, admitted that hackers breached its systems and stole the personal data of more than 1 million patients. In a data breach notification filed with the Maine attorney general’s office, NextGen Healthcare confirmed that hackers accessed the personal data of 1.
Zacks Investment Research
Here’s Why You Should Retain NextGen (NXGN) Stock for Now
Friday Apr 21 2023 at 12:56
NextGen’s (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.
Zacks Investment Research
NextGen’s (NXGN) New Cloud-Based Solution to Improve Workflow
Tuesday Mar 28 2023 at 12:58
NextGen’s (NXGN) latest product is expected to simplify connectivity for healthcare providers, thereby solving clinical data exchange challenges.
Zacks Investment Research
Here’s Why You Should Retain NextGen (NXGN) Stock for Now
Tuesday Mar 14 2023 at 12:58
NextGen’s (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.
Zacks Investment Research
NextGen (NXGN) Behavioral Health Suite Adopted by Compass Health
Friday Mar 03 2023 at 10:33
NextGen’s (NXGN) Behavioral Health Suite is expected to aid Compass Health in improving its workflow.
Zacks Investment Research
Nextgen Healthcare (NXGN) Up 2.3% Since Last Earnings Report: Can It Continue?
Thursday Feb 23 2023 at 12:48
Nextgen Healthcare (NXGN) reported earnings 30 days ago. What’s next for the stock?
Zacks Investment Research
NextGen (NXGN) Q3 Earnings Fall Shy of Estimates, Revenues Top
Wednesday Jan 25 2023 at 12:47
NextGen’s (NXGN) third-quarter fiscal 2023 results reflect strength in its Recurring revenues.
Zacks Investment Research
Nextgen Healthcare (NXGN) Q3 Earnings Miss Estimates
Tuesday Jan 24 2023 at 18:49
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of -3.70% and 1.08%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Seeking Alpha
NextGen Healthcare, Inc. (NXGN) Q3 2023 Earnings Call Transcript
Tuesday Jan 24 2023 at 18:45
NextGen Healthcare, Inc. (NASDAQ:NXGN ) Q3 2023 Earnings Conference Call January 24, 2023 5:00 PM ET Company Participants James Hammerschmidt – Senior Vice President, Finance, and Investor Relations David Sides – President and Chief Executive Officer Jamie Arnold – Chief Financial Officer Conference Call Participants Stephanie Davis – SVB Securities Jack Wallace – Guggenheim Securities Jailendra Singh – Truist Securities Sean Dodge – RBC Capital Markets Jessica Tassan – Piper Sandler George Hill – Deutsche Bank Operator Welcome to NextGen Healthcare Fiscal 2023 Third Quarter Results Conference Call. Hosting the call today from NextGen are David Sides, President and Chief Executive Officer; and Jamie Arnold, Chief Financial Officer.
Zacks Investment Research
3 Medical Info Systems Stocks Braving Industry-wide Headwinds
Tuesday Jan 17 2023 at 05:17
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
Seeking Alpha
Is NextGen An Appropriate Allocation Of Equity Risk To Act As A Defensive Overlay To Equity Portfolios?
Saturday Dec 10 2022 at 02:46
Defensive and resilient healthcare has a strategic and tactical role to play within allocation of equity risk. We’ve stated numerous times below the benefits of holding a low beta, low gamma allocation to help stabilize portfolio returns.
Zacks Investment Research
NextGen (NXGN) Buys TSI Healthcare to Boost Ambulatory Services
Friday Dec 02 2022 at 09:47
NextGen (NXGN) acquires TSI Healthcare which may further solidify NXGN’s position in the ambulatory healthcare space.
Zacks Investment Research
NextGen Healthcare (NXGN) Q2 Earnings Beat, FY23 View Up
Wednesday Oct 26 2022 at 12:02
NextGen’s (NXGN) second-quarter fiscal 2023 results reflect strength in both its revenue sources.
Seeking Alpha
NextGen Healthcare, Inc. (NXGN) Q3 2022 Earnings Call Transcript
Tuesday Oct 25 2022 at 21:37
NextGen Healthcare, Inc. (NASDAQ:NXGN ) Q3 2022 Earnings Conference Call October 25, 2022 5:00 PM ET Company Participants James Hammerschmidt – Senior Vice President, Finance and Investor Relations David Sides – President and Chief Executive Officer Jamie Arnold – Chief Financial Officer Conference Call Participants Stephanie Davis – SVB Securities Jack Wallace – Guggenheim Sean Dodge – RBC Capital Markets George Hill – Deutsche Bank Jessica Tassan – Piper Sandler Jailendra Singh – Truist Annie Samuel – JPMorgan Operator Good day, everyone and welcome to today’s NextGen Healthcare Second Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn today’s program over to James Hammerschmidt, Senior Vice President of Finance and IR.
Business Wire
NextGen Healthcare to Host Fiscal 2023 Second Quarter Results Conference Call on Oct. 25
Monday Oct 17 2022 at 08:00
ATLANTA–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it will release its fiscal 2023 second quarter ended Sept.
Zacks Investment Research
NextGen’s (NXGN) Enterprise Adopted by Oak Orchard Health
Wednesday Oct 05 2022 at 12:02
NextGen’s (NXGN) EHR and PM solution is expected to aid Oak Orchard Health in improving its workflow.
Zacks Investment Research
3 Reasons to Retain NextGen (NXGN) Stock in Your Portfolio
Thursday Sep 22 2022 at 14:18
NextGen’s (NXGN) strong product portfolio and solid prospects in the RCM space raise optimism about the stock.
NextGen Healthcare Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
NextGen Healthcare’s Altman Z-score is 2.83 which is in the gray zone. This indicates a level of ambiguity where further analyses are needed to evaluate the company’s financial stability accurately.
Derived from SEC.GOV filing dataopen_in_new
NextGen Healthcare Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, there has been no insider trading in NextGen Healthcare.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
NextGen Healthcare’s Income Quality of 17.08 is greater than its Industry Group of 0.34 (4923.5% greater)
NextGen Healthcare’s Income Quality of 17.08 is greater than its Major Industry Group of 0.42 (3966.7% greater)
NextGen Healthcare’s Income Quality of 17.08 is greater than its Sector of 0.5 (3316.0% greater)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
NextGen Healthcare’s Current Ratio of 2.23 is greater than its Industry Group of 1.78 (25.3% greater)
NextGen Healthcare’s Current Ratio of 2.23 is greater than its Major Industry Group of 1.69 (32.0% greater)
NextGen Healthcare’s Current Ratio of 2.23 is greater than its Sector of 1.59 (40.3% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (490.82 & -1.64)
Cannot compare a negative PE Ratio (490.82 & -0.68)
Cannot compare a negative PE Ratio (490.82 & -0.29)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
NextGen Healthcare’s PB Ratio of 2.81 is in line with its Industry Group of 2.57 (9.3% greater)
NextGen Healthcare’s PB Ratio of 2.81 is greater than its Major Industry Group of 2.08 (35.1% greater)
NextGen Healthcare’s PB Ratio of 2.81 is greater than its Sector of 1.88 (49.5% greater)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
NextGen Healthcare’s ROE of 0.01 is greater than its Industry Group of -0.12 (108.3% greater)
NextGen Healthcare’s ROE of 0.01 is greater than its Major Industry Group of -0.06 (116.7% greater)
NextGen Healthcare’s ROE of 0.01 is greater than its Sector of -0.04 (125.0% greater)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
NextGen Healthcare’s ROCE of 0.03 is greater than its Industry Group of -0.06 (150.0% greater)
NextGen Healthcare’s ROCE of 0.03 is greater than its Major Industry Group of -0.03 (200.0% greater)
NextGen Healthcare’s ROCE of 0.03 is greater than its Sector of -0.02 (250.0% greater)
Derived from SEC.GOV filing dataopen_in_new